THE SPECTRUM OF ASPERGILLOSIS IN LIVER-TRANSPLANT PATIENTS - COMPARISON OF FK-506 AND CYCLOSPORINE IMMUNOSUPPRESSION

被引：0
|
作者：
TORRECISNEROS, J
MANEZ, R
KUSNE, S
ALESSIANI, M
MARTIN, M
STARZL, TE
机构：
[1] UNIV PITTSBURGH,DEPT SURG,PITTSBURGH,PA 15260
[2] UNIV PITTSBURGH,DEPT INFECT DIS,PITTSBURGH,PA 15260
来源：
TRANSPLANTATION PROCEEDINGS | 1991年 / 23卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：3040 / 3041
页数：2
相关论文
共 50 条
  • [1] NEPHROTOXICITY OF FK-506 AND CYCLOSPORINE WHEN USED AS PRIMARY IMMUNOSUPPRESSION IN LIVER-TRANSPLANT RECIPIENTS
    PORAYKO, MK
    TEXTOR, SC
    KROM, RAF
    HAY, JE
    GORES, GJ
    WAHLSTROM, HE
    SANCHEZURDAZPAL, L
    RICHARDS, T
    CROTTY, P
    BEAVER, S
    WIESNER, RH
    TRANSPLANTATION PROCEEDINGS, 1993, 25 (01) : 665 - 668
  • [2] BIOASSAY OF PLASMA SPECIMENS FROM LIVER-TRANSPLANT PATIENTS ON FK-506 IMMUNOSUPPRESSION
    ZEEVI, A
    EIRAS, G
    BURCKART, G
    JAIN, A
    KRAGACK, A
    VENKATARAMANAN, R
    TODO, S
    FUNG, J
    STARZL, TE
    DUQUESNOY, RJ
    TRANSPLANTATION PROCEEDINGS, 1990, 22 (01) : 60 - 63
  • [3] PHARMACOKINETICS OF CYCLOSPORINE AND NEPHROTOXICITY IN ORTHOTOPIC LIVER-TRANSPLANT PATIENTS RESCUED WITH FK-506
    JAIN, AB
    VENKATARAMANAN, R
    FUNG, J
    BURCKART, G
    EMEIGH, J
    DIVEN, W
    WARTY, V
    ABUELMAGD, K
    TODO, S
    ALESSIANI, M
    STARZL, TE
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (06) : 2777 - 2779
  • [4] METABOLIC EFFECTS OF CYCLOSPORINE-A AND FK-506 IN LIVER-TRANSPLANT RECIPIENTS
    KRENTZ, AJ
    DOUSSET, B
    MAYER, D
    MCMASTER, P
    BUCKELS, J
    CRAMB, R
    SMITH, JM
    NATTRASS, M
    DIABETES, 1993, 42 (12) : 1753 - 1759
  • [5] NEUROTOXICITY OF FK-506 IN LIVER-TRANSPLANT RECIPIENTS
    FRANK, B
    PERDRIZET, GA
    WHITE, HM
    MARSH, JW
    LEMANN, W
    WOODLE, ES
    TRANSPLANTATION PROCEEDINGS, 1993, 25 (02) : 1887 - 1888
  • [6] A COMPARISON OF TACROLIMUS (FK-506) AND CYCLOSPORINE FOR IMMUNOSUPPRESSION IN LIVER-TRANSPLANTATION
    BUSUTTIL, RW
    MCDIARMID, S
    KLINTMALM, GB
    GOLDSTEIN, R
    MILLER, CM
    SCHWARTZ, M
    SHAW, BW
    ROBERTS, JP
    HEBERT, MF
    ESQUIVEL, CO
    NAKAZATO, P
    WIESNER, RH
    KROM, RAF
    KALAYOGLU, M
    DALESSANDRO, AM
    MARSH, JW
    PETERS, MG
    BURDICK, J
    KLEIN, A
    LEWIS, WD
    JENKINS, R
    THISTLETHWAITE, JR
    EMOND, JC
    JUSKO, WJ
    DAMBROSIO, R
    BUELL, D
    FITZSIMMONS, WE
    NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (17) : 1110 - 1115
  • [7] RENAL-FUNCTION AFTER CONVERSION FROM CYCLOSPORINE TO FK-506 IN LIVER-TRANSPLANT PATIENTS
    MCCAULEY, J
    FUNG, JJ
    BROWN, H
    DEBALLI, P
    JAIN, A
    TODO, S
    STARZL, TE
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (06) : 3148 - 3149
  • [8] LYMPHOPROLIFERATIVE DISORDER IN A LIVER-TRANSPLANT PATIENT ON FK-506
    FRAYHA, HH
    NAZER, H
    KALLOGHLIAN, A
    ANTONIUS, JI
    SABBAH, R
    LANCET, 1991, 337 (8736) : 296 - 297
  • [9] SIMILAR CLINICAL PRESENTATION OF NEUROTOXICITY FOLLOWING FK-506 AND CYCLOSPORINE IN A LIVER-TRANSPLANT RECIPIENT
    FREISE, CE
    ROWLEY, H
    LAKE, J
    HEBERT, M
    ASCHER, NL
    ROBERTS, JP
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (06) : 3173 - 3174
  • [10] FK-506 AS TREATMENT OF LATE ACUTE REJECTION IN LIVER-TRANSPLANT PATIENTS
    RUCAY, P
    SAMUEL, D
    FARGES, O
    REYNES, M
    BISMUTH, H
    TRANSPLANTATION PROCEEDINGS, 1995, 27 (01) : 1105 - 1106
12345